Clofarabine injection
Products billed under this code include Clofarabine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Clofarabine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Clofarabine | Dr. Reddy's Laboratories Inc. | 43598-0309-20 | 20 | $310.36 |
| Clofarabine | Apotex Corp | 60505-6166-00 | 20 | $310.36 |
| Clofarabine | FreseniUS Kabi USA, LLC | 63323-0572-70 | 20 | $310.36 |
| Clofarabine | Amneal Pharmaceuticals, LLC | 70121-1236-01 | 20 | $310.36 |
| Clofarabine | Meitheal Pharmaceuticals Inc. | 71288-0128-20 | 20 | $310.36 |
| Clofarabine | Fosun Pharma USA Inc. | 72266-0108-01 | 20 | $310.36 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $15.518 | −$0.727 | 1 MG | Clofarabine injection | v1, posted September 17, 2026 |
| 3Q26 | $16.245 | +$5.308 | 1 MG | Clofarabine injection | v1, posted September 15, 2026 |
| 2Q26 | $10.937 | −$3.432 | 1 MG | Clofarabine injection | v1, posted September 15, 2026 |
| 1Q26 | $14.369 | +$10.179 | 1 MG | Clofarabine injection | v1, posted September 15, 2026 |
| 4Q25 | $4.19 | −$10.528 | 1 MG | Clofarabine injection | v1, posted September 8, 2026 |
| 3Q25 | $14.718 | −$1.288 | 1 MG | Clofarabine injection | v1, posted March 10, 2026 |
| 2Q25 | $16.006 | +$7.551 | 1 MG | Clofarabine injection | v1, posted March 10, 2026 |
| 1Q25 | $8.455 | −$5.922 | 1 MG | Clofarabine injection | v1, posted December 19, 2025 |
| 4Q24 | $14.377 | +$5.192 | 1 MG | Clofarabine injection | v1, posted June 11, 2025 |
| 3Q24 | $9.185 | −$8.858 | 1 MG | Clofarabine injection | v1, posted June 11, 2025 |
| 2Q24 | $18.043 | −$3.342 | 1 MG | Clofarabine injection | v1, posted March 11, 2025 |
| 1Q24 | $21.385 | −$1.905 | 1 MG | Clofarabine injection | v1, posted December 19, 2024 |
| 4Q23 | $23.29 | −$6.134 | 1 MG | Clofarabine injection | v1, posted October 10, 2024 |
| 3Q23 | $29.424 | −$2.802 | 1 MG | Clofarabine injection | v1, posted June 5, 2024 |
| 2Q23 | $32.226 | −$5.792 | 1 MG | Clofarabine injection | v1, posted February 23, 2024 |
| 1Q23 | $38.018 | +$9.245 | 1 MG | Clofarabine injection | v1, posted December 6, 2023 |
| 4Q22 | $28.773 | −$19.622 | 1 MG | Clofarabine injection | v1, posted June 22, 2023 |
| 3Q22 | $48.395 | −$0.975 | 1 MG | Clofarabine injection | v1, posted June 9, 2023 |
| 2Q22 | $49.37 | −$12.284 | 1 MG | Clofarabine injection | v1, posted December 14, 2022 |
| 1Q22 | $61.654 | +$8.505 | 1 MG | Clofarabine injection | v1, posted June 8, 2022 |
| 4Q21 | $53.149 | −$11.793 | 1 MG | Clofarabine injection | v1, posted June 2, 2022 |
| 3Q21 | $64.942 | +$26.446 | 1 MG | Clofarabine injection | v1, posted June 2, 2022 |
| 2Q21 | $38.496 | +$8.318 | 1 MG | Clofarabine injection | v1, posted March 1, 2022 |
| 1Q21 | $30.178 | – | 1 MG | Clofarabine injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.